Department of Biomedical Informatics

diverse group of adults
July 5, 2016

Vanderbilt establishes innovation center to boost demographic representation in clinical trial enrollment

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.

By Bill Snyder
speed bump sign
July 5, 2016

New NIH-funded center to study inefficiencies in clinical trials

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

By Bill Snyder
June 2, 2016

‘Crowdsourcing’ project aims to refine data extraction from electronic health records

A research team at Vanderbilt University Medical Center (VUMC) will develop a crowdsourcing solution for generating a wide range of labeled data sets from electronic health records (EHRs).

By Paul Govern
March 31, 2016

Study looks at doctors’ response to genetic testing

A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.

By Paul Govern
February 25, 2016

VUMC to Lead pilot program for Precision Medicine Initiative Cohort Program

Federal officials with the White House and National Institutes of Health (NIH) announced today that Vanderbilt University Medical Center (VUMC) will lead the Direct Volunteers Pilot Studies under the first grant to be awarded in the federal Precision Medicine Initiative Cohort Program.

By John Howser
February 11, 2016

REDCap application to be available on commercial market

A version of a Web application developed at Vanderbilt University that helps academic scientists around the globe collect and manage their research data will soon be available on the commercial market.

By Bill Snyder
February 11, 2016

Precision medicine

Vanderbilt’s Joshua Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine and a recognized leader in the national Precision Medicine Initiative, delivered last week’s Flexner Discovery Lecture.
By VUMC News and Communications
January 28, 2016

Vanderbilt’s Denny set for next Flexner Discovery Lecture

Joshua Denny, M.D., M.S., who helped propel Vanderbilt University Medical Center into a leadership role in the national Precision Medicine Initiative, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 4.
By Bill Snyder
November 19, 2015

Harris honored by American Medical Informatics Association

Paul Harris, Ph.D., MS, professor of Biomedical Informatics and Engineering, has received the Donald A.B. Lindberg Award for Innovation in Informatics from the American Medical Informatics Association (AMIA).
By Paul Govern
October 1, 2015

New digital tools set to enhance patient experience at VUMC

Vanderbilt University Medical Center (VUMC) is introducing a host of customer-focused digital tools to increase access and help patients better manage their health.
By VUMC News and Communications
September 23, 2015

Data diving for health

To most effectively use electronic health records for research, investigators should query multiple components of the record to identify patients with specific diseases.
By VUMC News and Communications
September 10, 2015

Grants spur effort to add genetic data to EMR

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.
By Bill Snyder
July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.
By Bill Snyder